434 related articles for article (PubMed ID: 6524872)
21. Adrenoleukodystrophy: a fatal disorder with new opportunities for prevention and treatment.
O'Donnell-O'Toole S
J Neurosurg Nurs; 1985 Feb; 17(1):53-60. PubMed ID: 3844443
[TBL] [Abstract][Full Text] [Related]
22. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
Watkins PA; Naidu S; Moser HW
J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
[TBL] [Abstract][Full Text] [Related]
23. Adrenomyeloneuropathy presenting as Addison's disease in childhood.
Sadeghi-Nejad A; Senior B
N Engl J Med; 1990 Jan; 322(1):13-6. PubMed ID: 2294415
[TBL] [Abstract][Full Text] [Related]
24. Neonatal-onset adrenoleukodystrophy in a girl.
Haas JE; Johnson ES; Farrell DL
Ann Neurol; 1982 Nov; 12(5):449-57. PubMed ID: 6295256
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR
J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255
[TBL] [Abstract][Full Text] [Related]
26. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
[TBL] [Abstract][Full Text] [Related]
27. [Adrenoleukodystrophy: the significance of peroxisomal disease in adult neurology].
Gold R; Hunneman DH; Kappos L; Hanefeld F
Nervenarzt; 1990 Feb; 61(2):77-82. PubMed ID: 2320193
[No Abstract] [Full Text] [Related]
28. X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.
Mahmood A; Dubey P; Moser HW; Moser A
Pediatr Transplant; 2005 Dec; 9 Suppl 7():55-62. PubMed ID: 16305618
[TBL] [Abstract][Full Text] [Related]
29. Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles.
Berger J; Bernheimer H; Faé I; Braun A; Roscher A; Molzer B; Fischer G
Biochem Biophys Res Commun; 1995 Nov; 216(2):447-51. PubMed ID: 7488132
[TBL] [Abstract][Full Text] [Related]
30. X-linked adrenoleukodystrophy.
Moser HW; Mahmood A; Raymond GV
Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
[TBL] [Abstract][Full Text] [Related]
31. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
[TBL] [Abstract][Full Text] [Related]
32. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
33. [X-linked adrenoleukodystrophy--case reports of 4 patients in a family].
Dumić M; Ille J; Fumić K; Kacić-Milicić Z; Cvitanović M; Plavsić V; Spehar A; Janjanin N; Filipović-Grcić B
Lijec Vjesn; 2002; 124(8-9):258-62. PubMed ID: 12587436
[TBL] [Abstract][Full Text] [Related]
34. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
36. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
37. Dietary management of X-linked adrenoleukodystrophy.
Moser HW; Borel J
Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
[TBL] [Abstract][Full Text] [Related]
38. Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).
Powers JM
Clin Neuropathol; 1985; 4(5):181-99. PubMed ID: 2998664
[TBL] [Abstract][Full Text] [Related]
39. Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described.
Lachtermacher MB; Seuánez HN; Moser AB; Moser HW; Smith KD
Hum Mutat; 2000; 15(4):348-53. PubMed ID: 10737980
[TBL] [Abstract][Full Text] [Related]
40. [Adrenoleukodystrophy and adrenomyeloneuropathy].
Masson C
Presse Med; 1986 Jun; 15(23):1091-3. PubMed ID: 2942890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
